As 2025 winds down, we’re reflecting on a year defined by both advances in sequencing, and a shift toward truly integrated multiomics. Researchers across the Element community embraced 5D multiomics, combined readouts in new ways, and uncovered new layers of biology.
With better tools, more integrated workflows, and broader access to high-quality data, this year brought new insights, new applications, and new ways to get more biological context from every experiment.
Below, we’re taking a look back at the ideas, innovations, and milestones that shaped this year.
This year’s most-read stories highlighted the applications driving research forward in 2025. Readers gravitated toward content that illustrates how to combine modalities, increase the depth of biological characterization, and connect sequencing outputs with spatial and functional insights.
Our top blog posts included:
24 ways AVITI24™ can transform your research—A look at 24 ways the dual capabilities of AVITI24 are helping researchers take discovery to the next level.
Seeing deeper with optical pooled screening—An overview of the benefits and applications of optical pooled screening, and how Direct In Sample Sequencing (DISS) on AVITI24 is expanding what’s possible.
Uncovering rare variants and spatial heterogeneity: an interview with Dr. Suzuki—Dr. Suzuki shared how his lab is using Q50+ sequencing data and the multiomics capabilities of AVITI24 to uncover new insights in cancer biology.
There was a common theme among these stories: researchers are interested in expanding how and how much they can learn from every sample.
This year’s most-watched webinar captured the excitement around high-dimensional biology and the rapidly expanding tools they can use to explore it:
AVITI24 2025 Innovation Roadmap: high dimensional biology unlocked
The session walked through what was new for AVITI24 in 2025—from updated target panels and expanded customization options to support more sample types, new configurations, and the introduction of Direct In Sample Sequencing (DISS). Researchers tuned in to see what’s new today and what’s coming next.
This year brought a major milestone for the Element community: 300+ new publications and preprints citing the AVITI™ family.
It showed just how quickly researchers are adopting high-quality, flexible sequencing to drive their work forward. Across the globe, teams used AVITI and AVITI24 to power studies in cancer research, microbiology, agriculture, cardiovascular science and so much more.
The range of applications was incredible, and it reflected how ambitious and creative our community is. To showcase our growing number of citations, we created a publications hub where you can discover how others are using their AVITI.
As always, the excitement around new technology reached beyond the lab and showed up on our timelines too. Our most popular LinkedIn post was celebrating one of our biggest milestones: the 50th AVITI24 order just a few months after launch.
The community responded with enthusiasm. It was a simple moment, but a meaningful one, a snapshot of how quickly interest in high dimensional biology is growing.
The AVITI and AVITI24 community continued to grow this year, now at 500 instrument orders across nearly 60 countries. It was exciting to see researchers around the world, across universities, biotech companies, pharma, and core facilities, bringing these platforms into their work.
Teams used AVITI and AVITI24 to support everything from whole genome sequencing to emerging multiomics workflows, building momentum across their projects. This global growth reflects a shared commitment to generating high-quality data and accelerating discovery, no matter the scale or setting.
If 2025 showed us anything, it’s that this community is ready to move fast and think big. Multiomics is opening the door to new kinds of questions, and the pace of discovery has never been stronger.
We’re grateful for the curiosity and creativity you bring to this work, and we’re excited to keep building alongside you in the year ahead.
Here’s to everything we accomplished together—and to everything we’ll take on in 2026.